Cardiovascular disease remains a leading global health burden, yet many preclinical systems still struggle to predict how candidate drugs will perform in the human heart.
Heart disease remains a primary cause of illness and mortality around the world. While minimally invasive procedures have improved cardiac care, the heart’s complex anatomy and constant motion require ...